Efficacy of Inhaled Cannabis for Acute Migraine Treatment
NCT04360044
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
92
Enrollment
OTHER
Sponsor class
Conditions
Migraine
Cannabis
THC
CBD
Interventions
DRUG:
THC ~5%
DRUG:
CBD ~12%
DRUG:
THC ~5% and CBD ~12%
DRUG:
Sham Cannabis
Sponsor
University of California, San Diego
Collaborators
[object Object]